OWC Pharmaceutical Research Corp Reports Progress in Clinical …

RAMAT GAN, Israel, Nov. 29, 2018 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, reported today that the last healthy volunteer in its first ever safety study of cannabis-based topical ointment, was recently admitted in trial which is being conducted at Sheba Medical Center, Tel Hashomer, Israel. Mr. Mordechai Bignitz, OWC Pharmaceutical CEO commented: ” We are extremely pleased with the progress on this trial. Recruiting has now been completed and we expect to complete the trial by the end of December”.

Mr. Bignitz added: “We recently had the opportunity to present our innovative research and pipeline progress to investors and potential business partners at the MJBizCon in Las Vegas. We are evaluating a number of potential avenues to accelerate our

... read more at: https://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-to-report-progress-in-clinical-trials-for-ointment-care-for-skin-diseases-300757541.html

by